Security key
48669G105
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)
CUSIP: 48669G105
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / American Depositary Shares
- Total 13F shares
- 371,232
- Total 13F value
- $115,509
- Share change
- -4,548,006
- SEC-reported price per share
- $0.31
- Number of holders
- 11
- Value change
- -$1,994,451
- Number of buys
- 4
- Number of sells
- 13
- Shares outstanding
- 11,933,719
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
11
Top holders
10
KZIA full security history
Ownership snapshot
Full 13F holder table
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
Broader feeds
Ownership snapshot
Top reported holders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 21%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 21%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
21%
PLATINUM INVESTMENT MANAGEMENT LTD
15%
MORGAN STANLEY
1.7%
BANK OF MONTREAL /CAN/
1.2%
HSBC HOLDINGS PLC
0.84%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
21%
|
$1,088,006
2,475,555 shares
|
— | 31 Dec 2023 |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
Company
|
15%
|
$800,719
1,821,887 shares
|
— | 31 Dec 2023 |
| MORGAN STANLEY |
13F
Company
|
1.7%
|
$88,581
201,550 shares
|
— | 31 Dec 2023 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
1.2%
|
$65,878
140,166 shares
|
— | 31 Dec 2023 |
| HSBC HOLDINGS PLC |
13F
Company
|
0.84%
|
$45,087
100,194 shares
|
— | 31 Dec 2023 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.49%
|
$25,677
58,423 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
371,232
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
11
Q1 2024 holders
11
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|